适时转变。作者 I 岳笑笑报道 I 投资界-并购最前线一笔标杆性交易诞生。10月7日,港股嘉和生物发布公告,宣布与亿腾医药通过合并方式收购后者,合并后亿腾医药的大股东将会成为新主体的控股股东。当日,嘉和生物盘中股价一路暴涨超90%。经此一举,嘉和生物走出现金流困境,哺乳前端研发;此前四度IPO失败的亿腾医药,也得以圆满上市梦。作为港交所设立18A规则以来首个反向收购案例,这不仅拉开国内...
Source Link适时转变。作者 I 岳笑笑报道 I 投资界-并购最前线一笔标杆性交易诞生。10月7日,港股嘉和生物发布公告,宣布与亿腾医药通过合并方式收购后者,合并后亿腾医药的大股东将会成为新主体的控股股东。当日,嘉和生物盘中股价一路暴涨超90%。经此一举,嘉和生物走出现金流困境,哺乳前端研发;此前四度IPO失败的亿腾医药,也得以圆满上市梦。作为港交所设立18A规则以来首个反向收购案例,这不仅拉开国内...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.